Comportements oniriques violents :
Le trouble comportemental en sommeil paradoxal cause la manifestation de comportements oniriques pouvant être violents ➡️ https://t.co/jsyBCDevAm
@AriCuperfain@mak_mike@pchangmd@CAMHnews
Check out our new paper on REM sleep behaviour disorder, out today on @CMAJ, https://t.co/YeXyDcaI4w with co-authors @mak_mike and Brian Chang @CAMHResearch#sleep#REM#RBD
Check out our new paper describing a novel outpatient postdischarge treatment model, IRDT, for managing concurrent psychiatric and substance use disorders https://t.co/XJqqp7MSah @CAMHnews@UofTPsych
ATTN primary care physicians managing care for people living with #dementia. TDRA is hosting a CME-accredited virtual course: Updates on the Diagnosis & Treatment of Dementia (May 12, 2023). Learn about a MRI protocol available in primary care. Register: https://t.co/1WQ6C9yJcc
TDRA is pleased to welcome five new members to our Scientific Advisory Committee (SAC). The SAC brings perspective from each of TDRA’s partner institutions as well as a variety of stakeholders. Learn more about our new members: https://t.co/gCuaF656it
Mental illness is a brain disorder? Right?
We thought so.
Hang on though, our new study @JAMAPsych shows that poor body health is a more pronounced manifestation of mental illness than poor brain health.
https://t.co/4TFlt7awEY
🧵1/9
ChatGPT generates fake citations to research papers that don't even exist.
But you can make ChatGPT give you references to (real) published papers.
Here's how to do it:
Had an incredible weekend at the @ASAMorg conference as a Ruth Fox Memorial Scholar recipient. Learned so much about #addictionmedicine, esp for patients facing barriers in accessing services. Excited to continue these collaborations to help provide optimal care to our patients
As a longtime Readings of the Week follower, thanks @DavidGratzer for discussing our team's @CMAJ paper on depot buprenorphine. For those interested in learning who may benefit from this treatment, check out our recent paper https://t.co/3dV4nu1tvc
A new BMJ study explores COVID’s impact on mental health, burnout and professionalism among physicians, and @AriCuperfain on using buprenorphine for opioid use disorder treatment in @DavidGratzer’s latest #ReadingOfTheWeek
https://t.co/AvYSTdPK3H
La buprénorphine à libération prolongée :
Une injection sous-cutanée, une fois par mois permet de maintenir efficacement l’abstinence à l’égard des opioïdes illicites.
➡️ https://t.co/7sdTNeOmC5
@AriCuperfain@CAMHnews
A case report I worked on with Tianna Costa, Dr. Ari Cuperfain and Dr. Nitin Chopra was just published in the Canadian Journal of Addiction! Check it out :)
Maintaining Evidence-based Opioid Agonist Treatment During... : Canadian Journal of Addiction https://t.co/7oMeU9LXMz
One day left to submit your abstract for the CAGP-CCSMH 2023 ASM!
Click here for submission guidelines: https://t.co/KfNiHdSCVJ
We look forward to receiving your abstract and seeing you in St John's, Newfoundland!
New Submission deadline: March 28, 2023
Check out our new paper with @madelynnhannah and @CAMHResearch team describing a rotation from methadone -> buprenorphine (and eventually depot buprenorphine) through SROM as intermediate. https://t.co/mkFCjPlA5v @csam_smca@UofTPsych
Ever wondered how many symptoms make up all of adult psychopathology described in the DSM-5? It’s 628!
How many do you think repeat across multiple diagnoses? If you answered 231 symptoms repeating a total of 1022 times (median 3 times per symptom, range 2-22), good job!
🧵
New research from @camhnews clinician scientist @NikkiBozinoff and Robert Kleinman suggests that eliminating telephone-based care will decrease access to telemedicine services for vulnerable Canadians and exacerbate existing disparities